For its part, Abecma made $89 million in the second quarter, up 36% on the previous quarter with the increase driven by "expanded capacity and vector supply," according to BMS.

Spanish biotech SpliceBio has secured $135 million in series B financing to accelerate development of its experimental gene therapy, SB-007, for Stargardt disease and expand its broader pipeline of ...

The MHRA has approved serplulimab, the UK’s first anti-PD-1 antibody for extensive-stage small cell lung cancer, improving survival options for adults.

The MHRA advises that women taking GLP-1 medicines—such as Mounjaro, Ozempic, Wegovy, Saxenda, and Victoza—should use effective contraception while on these medications and for a certain ...

The MHRA has launched a new hub in Leeds (image credit: Pixabay) The Medicines and Healthcare products Regulatory Agency's (MHRA) new Leeds hub has been hailed as "fantastic news" for the region, with ...

Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed. Background Haemophilia A is an inherited bleeding ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has on 20th June 2025, approved serplulimab (Hetronifly) to treat adults with extensive-stage small cell lung cancer (ES-SCLC), which has ...

The Malta Hotels and Restaurants Association (MHRA) urged immediate action to address ongoing disruptions in Paceville and St Julian's, where excavation works, traffic congestion, and noise are ...

UK's medicine regulator said on Monday it has temporarily restricted the use of French vaccine maker Valneva's shot to protect against chikungunya, a virus transmitted by mosquitoes, in people ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved SFL Pharmaceuticals Deutschland’s Aumseqa (aumolertinib) to treat a subset of non-small cell lung cancer (NSCLC) patients.